European Day against Prostate Cancer Ministry of Health announcement Most common cancer in men in Europe 1 in 7 men will develop prostate cancer Over 95% of patients will be fully cured Usually the disease is asymptomatic and needs regular screening
15 September has been established as the European Day against Prostate Cancer, in order to inform and raise awareness among the male population of the Old Continent about the risks of prostate cancer and the possibility of treating it.
Prostate cancer is the most common cancer in men in Europe, and the second most common cancer in men worldwide. It is estimated that 1 in 7 men will develop prostate cancer in their lifetime.
The disease is considered relatively slow progressing, and for this reason it is particularly important to diagnose it in its early stages, when it is still only found in the prostate and is considered fully curable. When detected in the early stages, the percentage of patients who are fully cured is over 95% as there is now a plethora of treatment options available. But when diagnosed in advanced stages, the rate drops to 20% It is therefore very important to be diagnosed early, and men over the age of 50 should have their prostate screened every year.
As the disease isusually asymptomatic, it can only be detected in early stages through regular clinical screening, which should start at the age of 50.
The main tests of the prostate are a specific blood test measuring the prostate specific antigen PSA and prostate finger examination, in which the gland is palpated to see if there are any abnormalities in its size, shape and texture.
The combination of these two methods can give the most accurate information about the presence or absence of the disease. In cases of a family history of prostate cancer in first-degree relatives, screening should begin at age 45.
The choice of treatment is based on the degree of malignancy of the tumour, its size, the presence of metastases and age, as well as the general clinical condition of the patient.
Total removal of the prostate (radical prostatectomy) is the most common treatment for localised prostate cancer. It is usually performed between the ages of 50 and 70. Alternative treatment is radiation of the prostate (external brachytherapy) and in cases of metastatic prostate cancer, hormone therapy can inhibit further spread of the disease.
Early, regular screening is a simple procedure that protects men and saves lives!
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source